Full metadata record
DC FieldValueLanguage
dc.contributor.authorDeshpande, Pallavi-
dc.contributor.authorMohan, Vishwaraman-
dc.contributor.authorThakurdesai, Prasad-
dc.date.accessioned2016-11-24T15:08:38Z-
dc.date.available2016-11-24T15:08:38Z-
dc.date.issued2016-07-13-
dc.identifier.issn1611-2156-
dc.identifier.urihttp://hdl.handle.net/2003/35619-
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-17660-
dc.description.abstractThe objective of the present study was to evaluate acute oral toxicity, subchronic toxicity, and mutagenic potential of low molecular weight galactomannans based standardized fenugreek seeds extract (LMWGAL-TF) in laboratory animals rats as per Organization for Economic Co-operation and Development (OECD) guidelines. For the acute toxicity (AOT) study, LMWGAL-TF was orally administered to Sprague-Dawley (SD) rats at a dose of 2000 mg/kg with vehicle control (VC) group (n = 5 per sex per group) as per OECD guideline no. 423. For the repeated dose toxicity study, the SD rats were orally administered with a daily oral dose of LMWGAL-TF 250, 500 and 1000 mg/kg/day with VC group (n = 15 per sex) for a period of 90 days followed by a recovery period of 28 days as per OECD guideline no. 408. The effects on body weight, food and water consumption, organ weights with hematology, clinical biochemistry, and histology were studied. The mutagenic potential of LMWGAL-TF was tested using reverse mutation assay (AMES test, OECD guideline No. 471). The LMWGAL-TF did not show mortality or treatment-related adverse signs during acute (dose 2000 mg/kg) and subchronic (90-days repeated dose 250, 500 and 1000 mg/kg) administration. The LMWGAL-TF showed oral lethal dose (LD50) more than 2000 mg/kg during AOT study. The dose of 1000 mg/kg was found as no observed adverse effect level (NOAEL) in rats during subchronic toxicity study. Furthermore, LMWGAL-TF did not show mutagenic potential in vitro. In conclusion, LMWGAL-TF was found safe during acute and subchronic (90 days repeated dose) toxicity studies in rats with no mutagenicity.en
dc.language.isoen-
dc.relation.ispartofseriesEXCLI Journal;Vol. 15, 2016en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subjectlow molecular weight galactomannansen
dc.subjectfenugreek seed extracten
dc.subjectacute oral toxicityen
dc.subjectsubchronic toxicityen
dc.subjectmutagenicityen
dc.subjectOECD guidelinesen
dc.subject.ddc610-
dc.titlePreclinical safety evaluation of low molecular weight galactomannans based standardized fenugreek seeds extracten
dc.typeText-
dc.identifier.doi10.17179/excli2016-461-
dc.type.publicationtypearticle-
dcterms.accessRightsopen access-
eldorado.dnb.zdberstkatid2132560-1-
Appears in Collections:Original Articles

Files in This Item:
File Description SizeFormat 
Thakurdesai_13072016_proof.pdfDNB1.98 MBAdobe PDFView/Open


This item is protected by original copyright



All resources in the repository are protected by copyright.